Empagliflozin Regulates the AdipoR1/p-AMPK/p-ACC Pathway to Alleviate Lipid Deposition in Diabetic Nephropathy

Empagliflozin Regulates the AdipoR1/p-AMPK/p-ACC Pathway to Alleviate Lipid Deposition in Diabetic Nephropathy

Zhiqin Zhang, Lihua Ni, Lian Zhang, Dongqing Zha, Chun Hu, Lingli Zhang, Huiling Feng, Xiaobao Wei, Xiaoyan Wu Department of Nephrology, Zhongnan Hospital of Wuhan University, Wuhan 430071, People’s Republic of ChinaCorrespondence: Xiaoyan WuDepartment of Nephrology, Zhongnan Hospital of W...

Description complète

Enregistré dans:
Détails bibliographiques
Auteurs principaux: Zhang Z, Ni L, Zhang L, Zha D, Hu C, Feng H, Wei X, Wu X
Format: article
Langue:EN
Publié: Dove Medical Press 2021
Sujets:
diabetic nephropathy
empagliflozin
adipor1
p-ampk
p-acc
lipid
Specialties of internal medicine
RC581-951
Accès en ligne:https://doaj.org/article/c6559b1e83804d1083891959214085d3
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Internet

https://doaj.org/article/c6559b1e83804d1083891959214085d3

Documents similaires